| Structure | Chemical Name | CAS | MF |
|
(S)-N-((3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl) methyl)propionamide
|
216869-17-9
|
C17H22FN3O4
|
|
Piperidine-1-carboxylic acid, 4-diethoxyphosphoryl ethyl ester
|
216870-24-5
|
C12H24NO5P
|
|
Cyclopropanecarboxylic acid, 2-fluoro-, propyl ester, (1R,2R)-rel- (9CI)
|
216872-00-3
|
C7H11FO2
|
|
N-Methyl-3-bromo-4-fluorobenzenemethanamine
|
216873-74-4
|
C8H9BrFN
|
|
ETHYL 3-(4-CHLOROANILINE)-2-(2,5-DIOXOTETRAHYDROFURAN-3-YL)BUT-2-ENOATE
|
216876-53-8
|
C16H16ClNO5
|
|
Benzenamine, 4-(2-butenyloxy)- (9CI)
|
216877-37-1
|
C10H13NO
|
|
Cyclopentanecarboxylic acid, 2-hydroxy-, hydrazide, (1R,2S)- (9CI)
|
216879-03-7
|
C6H12N2O2
|
|
Cyclopentanecarboxamide, N,2-dihydroxy-, (1S,2R)- (9CI)
|
216879-10-6
|
C6H11NO3
|
|
Cyclohexanecarboxylic acid, 2-hydroxy-, hydrazide, (1S,2S)- (9CI)
|
216879-13-9
|
C7H14N2O2
|
|
Cyclohexanecarboxamide, 2-hydroxy-, (1S,2S)- (9CI)
|
216879-15-1
|
C7H13NO2
|
|
Cyclohexanecarboxamide, 2-hydroxy-, (1S,2R)- (9CI)
|
216879-17-3
|
C7H13NO2
|
|
Cyclohexanecarboxamide, N,2-dihydroxy-, (1S,2R)- (9CI)
|
216879-19-5
|
C7H13NO3
|
|
Butanoic acid, 2-ethyl-3-oxo-, hydrazide (9CI)
|
216879-60-6
|
C6H12N2O2
|
|
Cyclopentanecarboxylic acid, 2-oxo-, hydrazide (9CI)
|
216879-92-4
|
C6H10N2O2
|
|
Cyclopentanecarboxamide, N-hydroxy-2-oxo- (9CI)
|
216879-93-5
|
C6H9NO3
|
|
Cyclohexanecarboxamide, N-hydroxy-2-oxo- (9CI)
|
216879-94-6
|
C7H11NO3
|
|
1H-Indene-1-carboxamide, 2,3-dihydro-2-oxo-
|
216879-96-8
|
C10H9NO2
|
|
2-MERCAPTO-3-(3-METHOXY-PROPYL)-3 H-QUINAZOLIN-4-ONE
|
216880-47-6
|
C12H14N2O2S
|
|
2,3,4,5-tetradeoxy-2,5-epithio-erythro-Hexaric acid 2,5-diethyl ester
|
216884-00-3
|
C10H16O4S
|
|
Piperazine, 1-(ethenylsulfonyl)- (9CI)
|
216955-53-2
|
C6H12N2O2S
|
|
5-Thiazolecarboxylicacid,2-[(aminoiminomethyl)amino]-4-methyl-(9CI)
|
216955-55-4
|
C6H8N4O2S
|
|
4-METHYL-2-[1-(TERT-BUTOXYCARBONYL)PIPERID-4-YL]-1,3-THIAZOLE-5-CARBOXYLIC ACID
|
216955-61-2
|
C15H22N2O4S
|
|
6-(1H-IMIDAZOL-1-YL)NICOTINIC ACID
|
216955-75-8
|
C9H7N3O2
|
|
JUSNEESIINOL(RG)
|
216955-78-1
|
C20H14O7
|
|
Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(8H)-one, 5-(1,3-benzodioxol-5-yl)-5,9-dihydro-, (5R)-
|
216955-79-2
|
C20H14O6
|
|
5-(3'-HYDROXYBENZYL)HYDANTOIN
|
216956-20-6
|
C10H10N2O3
|
|
ETHYL N-(TERT-BUTOXYCARBONYL)OXAMATE
|
216959-34-1
|
C9H15NO5
|
|
Tert-Butyl Cinnamylcarbamate
|
216959-50-1
|
C14H19NO2
|
|
4-(1H-1,2,3-Triazol-1-yl)benzoic acid
|
216959-87-4
|
C9H7N3O2
|
|
4-(Pyrimidin-5-yl)benzoic acid
|
216959-91-0
|
C11H8N2O2
|
|
4-METHYL-2-(2-PYRAZINYL)-1,3-THIAZOLE-5-CARBOXYLIC ACID
|
216959-92-1
|
C9H7N3O2S
|
|
4-(2-AMino-4-thiazolyl)benzoic Acid
|
216959-94-3
|
C10H8N2O2S
|
|
4-(2-AMINOPYRIMIDIN-4-YL)BENZOIC ACID
|
216959-98-7
|
C11H9N3O2
|
|
4-(2-TERT-BUTOXYCARBONYLHYDRAZINO)CARBONYL-BENZOIC ACID
|
216959-99-8
|
C13H16N2O5
|
|
1-BOC-1,10-DIAMINODECANE
|
216961-61-4
|
C15H32N2O2
|
|
PYRIDINE,2-(2-CHLOROETHYL)-4-METHYL-
|
216961-75-0
|
C8H10ClN
|
|
10-(2-Carboxyethyl)-5,5-difluoro-1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide
|
216961-95-4
|
C16H19BF2N2O2
|
|
BODIPY
|
216961-98-7
|
|
|
DCDHFDA, SE [2',7'-Dichlorodihydrofluorescein diacetate, succiniMidyl ester]
|
216964-01-1
|
C28H19Cl2NO9
|
|
METHYL 3-BROMO-4-PROPOXYBENZOATE
|
216965-51-4
|
C11H13BrO3
|
|
5,6,7,8-TETRAHYDRO-6-METHYL-1,6-NAPHTHYRIDIN-3-AMINE
|
216966-37-9
|
C9H13N3
|
|
1H-Benzimidazole,5-ethynyl-(9CI)
|
216970-36-4
|
C9H6N2
|
|
2-Thiazoleacetamide, N-methyl-
|
216970-94-4
|
C6H8N2OS
|
|
6-CHLORO-3-INDOLYL-BETA-D-GLUCONORIDE SODIUM SALT
|
216971-56-1
|
C14H13ClNO7.Na
|
|
3-Indolyl--D-glucuronideCyclohexylammoniumsalt
|
216971-58-3
|
C20H28N2O7
|
|
1,5-Naphthalenedisulfonic acid, 2-8-amino-7-5-4-4-2-4-3-1-amino-7-(1,5-disulfo-2-naphthalenyl)azo-8-hydroxy-3,6-disulfo-2-naphthalenylazo-4-sulfophenylamino-6-chloro-1,3,5-triazin-2-ylaminoethyl-1-piperazinyl-6-chloro-1,3,5-triazin-2-ylamino-2-sulfophenyl
|
216972-32-6
|
C64H52Cl2N21NaO32S10
|
|
PSS-CHLORO-HEPTACYCLOPENTYL SUBSTITUTED&
|
216972-57-5
|
C35H63ClO12Si8
|
|
3 5 7 9 11 13 15-HEPTACYCLOPENTYLPENTA-&
|
216972-58-6
|
C35H64O13Si8
|
|
Carvedilol N'-CarbaMate β-D-Glucopyranuronic Acid
|
216973-68-1
|
C31H34N2O12
|
|
Carvedilol N-β-D-Glucuronide
|
216973-69-2
|
C30H34N2O10
|
|
Carvedilol N'-β-D-Glucuronide
|
216973-70-5
|
C30H34N2O10
|
|
|
Bevacizumab
|
216974-75-3
|
C6638H10160N1720O2108S44
|
|
3-Fluoro-5-methylbenzonitrile
|
216976-30-6
|
C8H6FN
|
|
Phenol, 3-fluoro-5-methyl- (9CI)
|
216976-31-7
|
C7H7FO
|
|
3'-Azido-3'-deoxy-beta-L-adenosine
|
216976-76-0
|
C10H12N8O3
|
|
1,1,7,7-Tetramethyljulolidine-9-carboxaldehyde
|
216978-79-9
|
C17H23NO
|
|
R-2,2'-bis(methoxymethoxy)-[1,1'-Binaphthalene]-3-carboxaldehyde
|
216978-80-2
|
C25H22O5
|
|
2-Furanpropanoic acid, alpha-chloro-beta-oxo-, methyl ester (9CI)
|
216979-16-7
|
C8H7ClO4
|
|
Pyridine, 2,3-diethynyl- (9CI)
|
216979-52-1
|
C9H5N
|
|
3-chloro-2-trimethylsilanylethynyl-pyridine
|
216979-76-9
|
C10H12ClNSi
|
|
2,4,7-TRIMETHYLDIBENZOTHIOPHENE
|
216983-03-8
|
C15H14S
|
|
N1-(4-([(4-CHLORO-3-NITROPHENYL)SULFONYL]AMINO)-3-METHYLPHENYL)ACETAMIDE
|
216984-77-9
|
C15H14ClN3O5S
|
|
ethyl 1-(4-nitrophenyl)-4-piperidinecarboxylate
|
216985-30-7
|
C14H18N2O4
|
|
[(3-CHLORO-BENZO[B]THIOPHENE-2-CARBONYL)-AMINO]-ACETIC ACID
|
216985-67-0
|
C11H8ClNO3S
|
|
4-(2-PIPERIDIN-2-YL-ETHYL)-MORPHOLINE
|
216985-68-1
|
C11H22N2O
|
|
15-Epi-Danshenol-A
|
216987-13-2
|
C21H20O4
|
|
1-(4-FLUOROPHENYL)-5-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID
|
217073-76-2
|
C11H9FN2O2
|
|
1,2-di-(9,10-dibroMo)stearoyl-sn-glycero-3-phosphocholine
|
217075-01-9
|
C44H84Br4NO8P
|
|
BODIPY 581/591 C11
|
217075-36-0
|
C30H34BF2N2O2.H
|
|
Benzoic acid, 4,4'-(1,4-phenylenedi-2,1-ethynediyl)bis-
|
217077-89-9
|
C24H14O4
|
|
APELIN PRECURSOR (61-77) (HUMAN, BOVINE, MOUSE, RAT) TRIFLUOROACETATE
|
217082-57-0
|
C96H156N34O20S
|
|
GLN-ARG-PRO-ARG-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE
|
217082-58-1
|
C69H111N23O16S
|
|
PYR-ARG-PRO-ARG-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE-OH
|
217082-60-5
|
C69H108N22O16S
|
|
Benzene, 1,5-difluoro-2-methoxy-3-methyl- (9CI)
|
217085-78-4
|
C8H8F2O
|
|
Esomeprazole magnesium trihydrate
|
217087-09-7
|
C34H38MgN6O7S2
|
|
Esomeprazole magnesium dihydrate
|
217087-10-0
|
C34H36MgN6O6S2.2H2O
|
|
D-erythro-Pentitol, 3,4,5-trideoxy-3-[[(1,1-dimethylethoxy)carbonyl]amino]-
|
217089-27-5
|
C10H21NO4
|
|
7-Bromo-2-chloro-6-methoxyquinoxaline
|
217093-62-4
|
C9H6BrClN2O
|
|
2-Azabicyclo[2.2.0]hex-5-ene-2-carboxylicacid,ethylester(9CI)
|
217093-71-5
|
C8H11NO2
|
|
2-Azabicyclo[2.1.1]hexane-2-carboxylicacid,ethylester(9CI)
|
217093-76-0
|
C8H13NO2
|
|
K-604 dihydrochloride
|
217094-32-1
|
C23H31ClN6OS3
|
|
2-Benzyloxy-3-nitro-benzoic Acid Benzyl Ester
|
217095-89-1
|
C21H17NO5
|
|
2-bromo-N-(6-methyl-2,4-bis(methylthio)pyridin-3-yl)acetamide
|
217096-06-5
|
C10H13BrN2OS2
|
|
3-AMINO-6-METHYL-2-(METHYLTHIO)PYRIDINE
|
217096-29-2
|
C7H10N2S
|
|
3-Pyridinamine, 2,4-dimethoxy-
|
217096-31-6
|
C7H10N2O2
|
|
Hugorosenone
|
217096-49-6
|
C20H30O2
|
|
CYCLO(-ARG-GLY-ASP-D-TYR-LYS)
|
217099-14-4
|
C27H41N9O8
|
|
Benzo[b]thiophene-2-carboximidamide, 6-(benzoyloxy)-
|
217099-39-3
|
C16H12N2O2S
|
|
2-(Aminoiminomethyl)benzo[b]thiophen-6-yl ester-2-Thiophenecarboxylic acid
|
217099-43-9
|
C14H10N2O2S2
|
|
2-Thiophenecarboxylic acid 2-(aminoiminomethyl)benzo[b]thiophen-6-yl ester methanesulfonate (1:1)
|
217099-44-0
|
C15H14N2O5S3
|
|
2-Benzothiazolecarboximidamide,6-hydroxy-(9CI)
|
217099-80-4
|
C8H7N3OS
|
|
N-[[4-(1,1-Dimethylethyl)phenyl]methyl-N-methyl-L-leucyl-N-(1,1-dimethylethyl)-O-phenylmethyl)-L-tyrosinamide
|
217171-01-2
|
C38H53N3O3
|
|
VINYL T-STRUCTURE POLYMER, 15-30 cSt
|
217174-00-0
|
(C2H6OSi)n(C2H6OSi)n(C2H6OSi)nC13H30O3Si4
|
|
(R,R)-1,1'-BIS[DINAPHTHO[1,2-D,1,2F][1,3,2]DIOXAPHOSPHEPIN-8-YL]FERROCENE
|
217175-10-5
|
C50H24FeO4P2
|
|
DHR 6G [DihydrorhodaMine 6G]
|
217176-83-5
|
C28H32N2O3
|
|
NEURODYE DI-12-ANEPPQ
|
217176-86-8
|
C47H77BrN3+
|
|
cMK801
|
217176-91-5
|
C26H24N2O6
|
|
bis(4-methyl-2-pyridyl)ketone
|
217177-31-6
|
C13H12N2O
|
|
Stampidine
|
217178-62-6
|
C20H23BrN3O8P
|
|
8-Azido-octanoic acid
|
217180-76-2
|
C8H15N3O2
|